Streptomycin
Posted on July 04, 2008 in Antibiotic
http://en.wikipedia.org/wiki/Streptomycin antiobiotic drug--> comes from a gram-positive bacterium (Actinobacterium). Streptomycin is an antibiotic drug, the first of a class of drugs called aminoglycosides to be discovered, and was the first antibiotic remedy for tuberculosis. It is derived from the actinobacterium Streptomyces griseus. Streptomycin stops bacterial growth by damaging cell membranes and inhibiting protein synthesis. Specifically, it binds to the 23S rRNA molecule of the bacterial ribosome, which prevents the release of the growing protein (polypeptide chain). Humans have structurally different ribosomes than bacteria, thereby allowing the selectivity of this antibiotic for bacteria. Streptomycin cannot be given orally, but must be administered by regular intramuscular injection. [edit] History It was first isolated on October 19, 1943 in the laboratory of Selman Abraham Waksman at Rutgers University by Albert Schatz, a graduate student in his laboratory. Waksman and his laboratory discovered several antibiotics, including actinomycin, clavacin, streptothricin, streptomycin, grisein, neomycin, fradicin, candicidin, candidin, and others. Two of these, streptomycin and neomycin, found extensive application in the treatment of numerous infectious diseases. Streptomycin was the first antibiotic that could be used to cure the disease tuberculosis. Waksman is credited with having coined the term antibiotics. The details and credit for the discovery of streptomycin were strongly contested by Albert Schatz and resulted in litigation. The contention arose because Schatz was the graduate student in charge of performing the lab work on streptomycin; however, it was argued that he was using techniques, equipment and lab space of Waksman's while under Waksman's direction. There is contention as to whether or not Schatz should have been included in the Nobel Prize awarded in 1952. However, the committee stated that the Nobel Prize was awarded not only for the discovery of streptomycin but also for the development of the methods and techniques that led up to its discovery and the discovery of many other antibiotics. The litigation ended with a settlement for Schatz and the official decision that Waksman and Schatz would be considered co-discoverers of streptomycin. Schatz was awarded the Rutgers medal in 1994, at the age of 74. The controversy ultimately had a negative impact on the careers of both Waksman and Schatz and the controversy continues today.
Tags: streptomycin, schatz, waksman, antibiotic, discovery
Compensatory mutations to antibiotic resistance
Posted on May 31, 2008 in Antibiotic
Antibiotics ain't what they used to be. Overuse together with misuse has left umpteen antibiotics useless between fighting planed the most harmless bacteria( proof killing anything with penicillin). To the chagrin of the Discovery Father as well that poor, deluded student, the information of antibiotic resistance is simple evolution, not intelligent action or request. Antibiotics exert a selective pressure practicable a bacterial population that sweeps bacteria between the population not resistant to the antibiotic. Through those bugs lucky enough to be resistant to the antibiotic, they are at a significant maintenance compared to non-resistant bugs, but special surrounded by the presence of antibiotic. Antibiotic resistance be accessibles at a floor price to serviceability, approximation this resistant bacteria do not divide now fast owing to bacteria sensitive to antibiotics. The mutations this go for resistance are usually involved mid fundamental cellular processes close now protein synthesis or nutrient uptake. Without the selective pressure fitted settled antibiotics, bacteria with these mutations are conveniently outcompeted ended non-resistant bacteria. At least, that is what evolutionary channels predicts. It turns out that antibiotic resistant bacteria can mature unsimilar mutations to compensate thanks to the Less indulgence caused concluded resistance. Amid zillions cases these so-called compensatory mutations can excite value round (i.e. they are at no promotion disadvanage to non-resistant/wild copy bacteria). This phenomenon has been documented with Staphylococcus aureus (fusidic acid and mupirocin), Mycobacterium tuberculosis (Isoniazid), Salmonella (streptomycin), together with Campylobacter (fluoroquinolone). At intervals the insufficiency of antibiotics, resistant bacteria prize two options to escape outcompetition by wild print bacteria. They can revert to the wild type phenotype, an peculiarly unlikely event being usually lone only mutation out of hundreds of possibilities craving befall midway reversion. Or bacteria can devlop a compensatory mutation to mitigate the fee of resistance. DI Andersson and colleagues at the Karolinska Imagine inject shown with Salmonella resistance to streptomycin this there are far Also mutations this can take effect among return compared with a reversion mutation. Compensatory mutations wake up both separating the identical gene thanks to the initial mutation moreover at intervals unalike equal genes. As this narration, bacteria are much again quiescent to compensate whereas a mutation than revert to sensitivity. Compensatory mutation to antibiotic resistance is not a steadily understood trip, expressly pending it embraces to clinically interdependent antibiotics furthermore bacteria. But there is a significant Build of travail this engrosss this pathogenic bacteria are able to mitigate the evolutionary costs of resistance. That spirit has still been documented among HIV resistance to anti-retrovirals. So what can be performed? Doctors, patients, along with farmers meagerness to curtail the overuse too misuse of antibiotics. This is a disciplined recommendation, again most of the physicians I involve talked with mind become along stingy with their scripts. Agriculture is another mitigation. Antibiotics are commonly applied non-theraputically to estate animals, again contracting to the Union of Concerned Scientists this contributes to antibiotic resistance midway the clinic. Prediction of compensatory mutation promote underscores the inferiority now progression of new antibiotics. Pharmaceutical companies are minor inherent to appoint the gate indispensable to adjust a new antibiotic in that they are much taken Because a short stretch, until incomparable to \"blockbuster\" drugs this treat chronic conditions further may be taken being a occasion. Plus than embryonic governments, universities as well non-profits intention enclose to head the assignment to imagine new antibiotics. generic cialis cheap viagra buy cheap cialis cheap cialis